Torque teno virus viremia and QuantiFERON®-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients

Archive ouverte

Mafi, Sarah | Essig, Marie | Rerolle, Jean-Philippe | Lagathu, Gisèle | Crochette, Romain | Brodard, Véronique | Schvartz, Betoul | Gouarin, Stephanie | Bouvier, Nicolas | Engelmann, Ilka | Garstka, Antoine | Bressollette-Bodin, Céline | Cantarovitch, Diego | Germi, Raphaële | Janbon, Benedicte | Archimbaut, Christine | Heng, Anne-Elizabeth | Garnier, Françoise | Gomes-Mayeras, Melissa | Labrunie, Anaïs | Hantz, Sébastien | Alain, Sophie

Edité par CCSD ; Frontiers media -

International audience. Conclusion: The combination of TTV load and QF-Ag or TTV load and QF-Mg could be useful in stratifying the risk of CMV reactivation in R+ KTR during the first post-transplant year and thereby have an impact on the duration of prophylaxis in these patients.

Suggestions

Du même auteur

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study

Archive ouverte | Lebeaux, David | CCSD

International audience. Background.Solid organ transplant (SOT) recipients are at risk of nocardiosis, a rare opportunistic bacterial infection, but prognosis and outcome of these patients are poorly defined. Our ob...

Evaluation of the fully automated LIAISON®XL chemiluminescence analyzer for QuantiFERON®-CMV testing in transplant recipients. Évaluation de l'analyseur par chimiluminescence LIAISON®XL entièrement automatisé pour le test QuantiFERON®-CMV chez les receveurs de greffe

Archive ouverte | Mafi, Sarah | CCSD

International audience. Background: Monitoring CMV-specific cell-mediated immunity by the QuantiFERON®-CMV (QF-CMV) may beuseful in predicting the risk of CMV infection in transplant recipients (TR).Objectives: As t...

Challenges and advances in the management of HCMV infections. Enjeux et avancées de la prise en charge des infections à CMVH

Archive ouverte | Gourin, Claire | CCSD

International audience. Human cytomegalovirus (HCMV) is one of the most important causes of complications in immunocompromised patients and congenital infections. HCMV could also represent an interesting target for ...

Chargement des enrichissements...